COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
This COVID-19 antibody test allows consumers to collect blood using a finger stick, then send the dried sample for laboratory analysis.
This new government contract emphasizes a continued interest in expanding COVID-19 testing capabilities in the US, even as the vaccine rollout is well underway and cases are declining in most locations.
New FDA webpage provides new information about how SARS-CoV-2 variants impact COVID-19 testing and how clinical laboratories can respond.
Three new authorizations granted by the FDA for over-the-counter and point-of-care COVID-19 tests used for serial testing.
The FDA has taken steps to streamline the path for COVID-19 screening tools, providing information to help groups establish mass COVID-19 testing programs.
The FDA says data was reviewed from a clinical study of more than 500 test samples and a variety of analytical studies, which demonstrated a reasonable assurance that this COVID-19 test was safe and effective at identification and differentiation of various respiratory viral and bacterial pathogens.
This COVID-19 antibody test allows consumers to collect blood using a finger stick, then send the dried sample for laboratory analysis.
This new government contract emphasizes a continued interest in expanding COVID-19 testing capabilities in the US, even as the vaccine rollout is well underway and cases are declining in most locations.
New FDA webpage provides new information about how SARS-CoV-2 variants impact COVID-19 testing and how clinical laboratories can respond.
Three new authorizations granted by the FDA for over-the-counter and point-of-care COVID-19 tests used for serial testing.
The FDA has taken steps to streamline the path for COVID-19 screening tools, providing information to help groups establish mass COVID-19 testing programs.
The FDA says data was reviewed from a clinical study of more than 500 test samples and a variety of analytical studies, which demonstrated a reasonable assurance that this COVID-19 test was safe and effective at identification and differentiation of various respiratory viral and bacterial pathogens.
